Collegeville, PA, United States of America

Antony N Shaw

USPTO Granted Patents = 14 (Patent Applications = 6)

CIPO Patents = 3

EPO Patents = 4 (Patent Applications = 2)

Average Co-Inventor Count = 4.0

ph-index = 5

Forward Citations = 64(Granted Patents)

Location History:

Chester Springs, PA (US) (2004)
King of Prussia, PA (US) (2013)
Collegeville, PA (US) (2005 - 2023)

Company Filing History:

Smithkline Beecham Corporation

patents

1 out of 134

Ligand Pharmaceuticals, Inc.

patents

where one patent can have more than one assignee

Years Active: 2004-2023

Loading Chart...

14 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11643397 - Prolyl hydroxylase inhibitors (2023-05-09),

2. 10336711 - Prolyl hydroxylase inhibitors (2019-07-02),

3. 10035779 - Prolyl hydroxylase inhibitors (2018-07-31),

4. 8815884 - Prolyl hydroxylase inhibitors (2014-08-26),

5. RE44613 - N-substituted glycine derivatives: hydroxylase inhibitors (2013-11-25),

6. 8557834 - Prolyl hydroxylase inhibitors (2013-10-15),

7. 8324208 - Prolyl hydroxylase inhibitors (2012-12-04),

8. 7674887 - Thrombopoietin mimetics (2010-03-09),

9. 7608621 - N-substituted glycine derivatives: hydroxylase inhibitors (2009-10-27),

10. 7452874 - Thrombopoietin mimetics (2008-11-18),

11. 7332481 - Thrombopoietin mimetics (2008-02-19),

12. 7241783 - Thrombopoietin mimetics (2007-07-10),

13. 6875786 - Thrombopoietin mimetics (2005-04-05),

14. 6720345 - Semicarbazone derivatives and their use as thrombopoietin mimetics (2004-04-13),

Title: The Innovative Contributions of Antony N Shaw

Introduction

Antony N Shaw is a notable inventor based in Collegeville, PA (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of 14 patents to his name, Shaw has made remarkable advancements, particularly in the area of prolyl hydroxylase inhibitors.

Latest Patents

Shaw's latest patents focus on prolyl hydroxylase inhibitors. The inventions described relate to certain pyrimidinetrione N-substituted glycine derivatives of formula (I), which act as antagonists of HIF prolyl hydroxylases. These compounds are particularly useful for treating diseases that benefit from the inhibition of this enzyme, with anemia being a prime example.

Career Highlights

Throughout his career, Antony N Shaw has worked with prominent companies such as GlaxoSmithKline LLC and SmithKline Beecham Corporation. His work in these organizations has contributed to the development of innovative therapeutic solutions.

Collaborations

Shaw has collaborated with notable colleagues, including Kevin J Duffy and Kenneth Wiggall, enhancing the impact of his research and inventions.

Conclusion

Antony N Shaw's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the treatment of various diseases, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.